Cargando…
Onco-proteogenomics identifies urinary S100A9 and GRN as potential combinatorial biomarkers for early diagnosis of hepatocellular carcinoma
Hepatocellular carcinoma (HCC), the major type of liver cancer, is among the most lethal cancers owing to its aggressive nature and frequently late detection. Therefore, the possibility to identify early diagnostic markers could be of significant benefit. Urine has especially become one of the most...
Autores principales: | Huang, Chun-Hao, Kuo, Chao-Jen, Liang, Shih-Shin, Chi, Shu-Wen, Hsi, Edward, Chen, Chi-Chao, Lee, King-Teh, Chiou, Shyh-Horng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4669941/ https://www.ncbi.nlm.nih.gov/pubmed/26675302 http://dx.doi.org/10.1016/j.bbacli.2015.02.004 |
Ejemplares similares
-
White matter hyperintensities are seen only in GRN mutation carriers in the GENFI cohort
por: Sudre, Carole H., et al.
Publicado: (2017) -
Gray matter changes in asymptomatic C9orf72 and GRN mutation carriers
por: Popuri, Karteek, et al.
Publicado: (2018) -
Clinical Proteomics Identifies Urinary CD14 as a Potential Biomarker for Diagnosis of Stable Coronary Artery Disease
por: Lee, Min-Yi, et al.
Publicado: (2015) -
Onco-proteogenomics: a novel approach to identify cancer-specific mutations combining proteomics and transcriptome deep sequencing
por: Helmy, Mohamed, et al.
Publicado: (2010) -
Cerebral blood flow in presymptomatic MAPT and GRN mutation carriers: A longitudinal arterial spin labeling study()
por: Dopper, Elise G.P., et al.
Publicado: (2016)